General Updates

September 10, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 001 Mumbai – 400 051 Scrip Code No: 542665 Company Symbol: NEOGEN Debt Segment Code: 977028 Dear Sir/Madam, Re: Qualified institutions placement of equity shares of face value of ₹10 each (the “Equity Shares”) by Neogen Chemicals Limited (the “Company”) (the “QIP” or “Issue”) in terms of the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”), and Section 42 and Section 62 of the Companies Act, 2013, as amended (the “Companies Act”) read with the rules issued thereunder. Sub: Outcome of the meeting of the Fund-Raising Committee held on September 10, 2026 We wish to inform you that pursuant to the approval of the Board of Directors of the Company (the “Board”) at its meeting held on July 24, 2026, and approval of the shareholders of the Company by way of a special resolution passed on August 21, 2026 (the “Shareholders’ Approval”), the Fund Raising Committee of the Company (the “Committee”), in its meeting held today i.e. September 10, 2026, which commenced at 6:30 p.m. and concluded at 7:15 p.m. has inter alia considered and approved the following: (i) approval and adoption of the preliminary placement document dated September 10, 2026, and the draft of application form to be sent to eligible qualified institutional buyers inviting bids and for the purpose of receiving filled in application forms along with application amounts for subscription of equity shares, in connection with the QIP; (ii) authorizing the opening of the proposed issue of such number of Equity Shares to eligible qualified institutional buyers through a qualified institutions placement under Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”) and Section 42 of the Companies Act, 2013, read with Rule 14 of the Companies (Prospectus and Allotment of Securities) Rules, 2014, each as amended, today, i.e. on September 10, 2026; (iii) approval of the floor price for the QIP, being ₹ 2,189.73 per Equity Share (“Floor Price”) calculated based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR Regulations. We further wish to inform you that the Fund-Raising Committee has fixed the ‘Relevant Date’ for the purpose of the QIP, in terms of Regulation 171 (b)(i) of the SEBI ICDR Regulations as September 10, 2026 and accordingly the floor price in respect of the QIP, based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR Regulations is ₹ 2,189.73 per Equity Share. Pursuant to Regulation 176(1) of the SEBI ICDR Regulations, the Company may, at its discretion, offer a discount of not more than 5% (five percent) on the Floor Price so calculated for the QIP. The Floor price shall not be less than the price determined in accordance with the pricing formula provided under Chapter VI of the SEBI ICDR Regulations. Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 The Issue price will be determined by the Company in consultation with the lead managers (the ‘LMs’) appointed for the Issue. In this relation, we will file the preliminary placement document dated September 10, 2026, with the BSE Limited and National Stock Exchange of India Limited on September 10, 2026. Copy of the same is also being made available on the website of our Company at https://neogenchem.com/announcements/ under the tab Issue of Securities Kindly take the above information on your records. Thanking you, Yours faithfully, For Neogen Chemicals Limited Unnati Kanani Company Secretary and Compliance Officer Mem. No. A35131 Place: Thane Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919